Is (90)Y-DOTATOC treatment for neuroendocrine tumours safe?
Markus Cybulla, Stefan M Weiner, Andreas Otte
Med Sci Monit 2002; 8(4): BR
ID: 420884
Available online:
Published:
Keywords: Animals, Antineoplastic Agents, Hormonal, Carcinoma, Medullary, Hypertension, Renal, Kidney Failure, Chronic, neuroendocrine tumors, octreotide, Radiopharmaceuticals, Receptors, Somatostatin, Thyroid Neoplasms, Yttrium Radioisotopes
